BIT Congress Inc.
 
News
 
News

Focus on IDDST, Focus on Frontier Drug Discovery Science

2016-06-16
BIT's 14th Annual Congress of International Drug Discovery Science and Technology-South Korea 2016 (IDDST-South Korea 2016), hosted by BIT Group Global Ltd., supported by Goyang City, Gyeonggi MICE Bureau and Gyeonggi Tourism Organization, was grandly held in Korea International Exhibition Center (KINTEX), Gyeonggi, South Korea on June 16th. More than 180 specialists from 35 countries and areas attended the 3-days congress. The opening ceremony and the forum was conducted by Jianxun Xie, Director of toxicology of Shanghai Innovation Center of Roche Pharmaceuticals Ltd., and many honored guests delivered brilliant keynote speeches which last approximately three hours, among them are: Dr. Chris Senanayake, Vice President of Department of Chemical Development in Boehringer Ingelheim Pharmaceuticals, Inc.; Dr. Bruce Given, COO of Arrowhead Research Corporation; Dr. Joseph P. Thomas, Chair of the Life Sciences Group and Co-chair of the Litigation Department in Ulmer & Berne LLP; Mr. Sean Hall, CEO of Medlab Clinical Ltd.; Dr. Seonggu Ro, Executive Vice President & CTO of Crystal Genomics, Inc. 鈥tc. This Congress comprised 20 sessions, on which more than 130 specialists gave wonderful speeches.

Add: East Wing, F11, Block 1, Dalian Ascendas IT Park, No.1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609    Fax: 0086-411-84799629
Email: info@bitcongress.com
Copyright 漏 2009-2012. BIT Congress Inc., BIT Group Global Ltd. 聽All Rights Reserved

MEMBER OF